📢 Upcoming Educational Webinar How Clinicians and Patients Talk About Herpes: Bridging the Disconnect Despite HSV’s prevalence, many patients face stigma, limited education, and gaps in care. 📅 March 5 | 5–6 PM EST 🔗 Register: us06web.zoom.us/meeting/regi...

Phase 1B data presented by Dr. Grace Wang showed promising reductions in viral shedding and outbreaks for investigational long-acting HSV therapies. Science is moving — and HSV research continues to progress. youtu.be/MGhR42Ka2KM?... #Virology #LongActingTherapies #MedicalScience #EndTheStigma

🔴 DAY OF EVENT TODAY is the day. Join us for an exclusive scientific discussion with Assembly Bio on advancing long-acting treatments for recurrent genital herpes.

🚀 1 DAY BEFORE Tomorrow. We go deep into the science shaping the future of recurrent genital herpes treatment. Join us for: 🧬 Clinical trial insights 💊 Long-acting therapy development 📈 Phase 2 outlook

🔬 2 DAYS BEFORE In 48 hours, we’re talking about the real impact of recurrent genital herpes—and how science is working toward better solutions. From epidemiology to patient experience to the next wave of antiviral development, this session is a must-attend.

⏰ 3 DAYS BEFORE 3 days to go until we spotlight cutting-edge research in recurrent genital herpes. Dr. Grace Wang, VP of Clinical Development at Assembly Biosciences, will present on: • ABI-5366 • ABI-1179 • The future of long-acting HSV therapies

New video: Herpes Cure Pipeline 4.0 (2025) 🎥 An in-depth look at emerging treatments, long-acting innovations, and scientific progress toward a cure for HSV. Watch now: youtube.com/watch?v=lGD6... #HerpesCure #HSV #HerpesResearch #ClinicalTrials #CureForHerpes

Did you know that long-acting antiviral therapies are being developed to transform how recurrent genital herpes is treated? On February 5th, we’re hosting Assembly Biosciences for a deep dive into: 🔬 Emerging long-acting HSV treatments 📊 Clinical trial findings 🧠 The future of patient care

New HCA-Supported Research 🔬 Published in the International Journal of STD & AIDS, this study explores whether a history of genital herpes symptoms predicts HSV-2 antibody positivity.

New HCA-Supported Research 🧬 A review published in the Journal of the Pediatric Infectious Diseases Society analyzes how neonatal herpes is reported across U.S. states and reveals significant gaps and inconsistencies in current policies.

New HCA-Supported Research 📊 A recent study in Sexually Transmitted Diseases examines patterns of congenital syphilis in a large public hospital, highlighting key maternal risk factors and infant outcomes.

New HCA-Supported Research 📄 We’re proud to highlight a new systematic review protocol examining the association between HSV-1 and dementia, published in BMJ Open.

🔔Starting in 1 hour ⏳ From discovery to cure: the complex path of antiherpetic drug development 🎤 Luis Schang, MV, PhD Join us live at 6pm EST. 🔗 us06web.zoom.us/meeting/regi...

🔔 DAY OF Today’s the day. From discovery to cure: the complex path of antiherpetic drug development 🎤 Luis Schang, MV, PhD 🕕 6:00pm EST Last chance to register: 🔗 : us06web.zoom.us/meeting/regi...

🔔 1 DAY OUT Goal: Urgency ⏰ Tomorrow! Join HCA for our first educational talk of 2026: From discovery to cure: the complex path of antiherpetic drug development 🎤 Luis Schang, MV, PhD 🗓 Jan 13 | 6pm EST

🔔 3 DAYS OUT Goal: Audience expansion + sharing If you’re involved in research, healthcare, or advocacy around herpes, this is a session you won’t want to miss.

🔔 5 DAYS OUT! In our upcoming HCA talk, Dr. Luis Schang will break down: • Why “promising” therapies stall • Where bottlenecks occur • How antivirals like valacyclovir made it through — and why others struggle 🗓 Jan 13 | 6pm EST 🔗 Register: us06web.zoom.us/meeting/regi...

We often hear about promising antiherpetic drugs… then nothing. Why does that happen? Where are the bottlenecks? Join HCA on Jan 13 at 6pm EST for a deep dive into the antiviral development pipeline with Luis Schang, MV, PhD — from lab discovery to clinical approval, with real HSV case studies.

Research is advancing. Clinical trials are progressing. A herpes cure is no longer a distant idea — it’s a real scientific pursuit.

We are closer to a herpes cure than ever before — and funding matters. ✨ Every gift fuels research awareness ✨ Every share fights stigma ✨ Every dollar brings us closer to a cure Give hope before the year ends. herpescureadvocacy.com/ways-to-give/ donatestock.com/herpes-cure-...

Major update in HSV-2 research👇 Assembly Biosciences just released Phase 1b results showing: • 91% fewer confirmed lesions • 76–94% reduction in viral shedding • 99%+ drop in high-viral-load samples

This #GivingTuesday, we’re fighting stigma and pushing for real progress toward an HSV cure. Give today: herpescureadvocacy.com/ways-to-give/

Did you miss our #herpesawarenessday talk on better testing for #herpes? We have it recorded and you can find it and all our other educational talks on our website under Recorded Talks! Have a topic you're interested in learning more of? Let us know! herpescureadvocacy.com/recorded-tal...

More good news from AssemblyBio who expects to initiate phase 2 of ABI-5366 in mid 2026! investor.assemblybio.com/news-release...

Did you know tomorrow is National #Herpes Awareness Day? In honor of it, we are hosting a talk with Dr. Camerini on the Development of Better Serological Tests for Herpes. We hope you join us! herpescureadvocacy.com/event/develo...

It’s spooky season! And we have a some great events for you this month! Next week, Dr. David Leib will give a talk on neonatal herpes! More info below: herpescureadvocacy.com/event/therap...

Herpes Simplex Virus 1-Encoded Tegument Protein VP16 Abrogates the Production of Beta Interferon (IFN) by Inhibiting NF-κB Activation and Blocking IFN Regulatory Factor 3 To Recruit Its Coactivator CBP | Journal of Virology journals.asm.org/doi/10.1128/... @asm.org @herpesadvocate.bsky.social

Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025. The company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overview. #herpes www.biospace.com/press-releas...

Join us in urging CSTE to make neonatal herpes a reportable condition. Call or email CSTE leadership today — your voice can help save newborn lives and strengthen public health tracking! #Herpes #CureHSV herpescureadvocacy.com/2025/09/11/h...

Herpes affects millions — and still lacks a cure. Join us at #RallyMedRes to demand more NIH funding for herpes research. It’s time to be seen. #FundNIH rallyformedicalresearch.org

"findings suggest that melatonin effectively protects neuronal cells against HSV-1 gD-induced oxidative stress". With more research showing linkage between #herpes and #Alzheimer's could studies like this one further the connection? www.sciencedirect.com/science/arti...

"Unexpectedly, we found that engineering antibodies into a bispecific format targeting two viral glycoproteins dramatically increased antiviral potency[...]demonstrating that delayed dosing after latency establishment can reduce disease" #herpes www.sciencedirect.com/science/arti...

Are you signed up for our newsletter? Each month, we share the latest news, upcoming events, and ways to take action. Don’t miss out—join our mailing list to stay informed and engaged! #herpes #curehsv herpescureadvocacy.com/members/

We are looking for impact stories for future marketing content. If you are willing, please let us know: 🔵How have you benefitted from HCA resources (website, events, etc.)? 🔵Why do you donate to HCA? Either time if you're a volunteer or monetary donations? #herpes #curehsv

Did you know we're on YouTube? If you missed our patient/provider panel discussion from last week, you can watch the recording on Youtube or under the Recorded Talks section of our website! What other topics would you like to see HCA have? #Herpes www.youtube.com/@herpescurea...

We’re growing our movement and need motivated people to join us! Whether you have experience in fundraising, policy work, or you’re simply passionate about driving change— your skills can help push our efforts forward. #CureHSV Learn more here: herpescureadvocacy.com/2025/08/20/a...

We had a great turnout at todays patient/provider panel! Thank you to all the participants & advocates that showed up! This is how we start bridging those gaps! If you were unable to attend, you can find the recording below under 2025 talks! #Herpes herpescureadvocacy.com/recorded-tal...

Today is the day! Patient/Provider discussion panel! More info below: herpescureadvocacy.com/event/hsv-pa...

Great article from two of our very own board members! Advocacy can come in many forms, this is one such way that sheds light on the issue and raises awareness! #SilentNoMore #CureHSV www.medpagetoday.com/opinion/seco...

Did you know Sunday's are a great time to start your advocacy efforts? Check out our advocates starter guide on ways you can get involved! We all have a voice to use! #SilentNoMore #CureHSV herpescureadvocacy.com/2021/10/16/n...

Nearly 100 people have registered for our upcoming patient/provider panel! Don’t miss your chance to be part of this important conversation—check out the details & sign up today. This discussion will spark the dialogue we need to move forward together. herpescureadvocacy.com/event/hsv-pa...

Curious what research is happening for herpes? Check out our Herpes Cure Pipeline 4.0! herpescureadvocacy.com/2025/04/22/h...

AssemblyBiosciences latest press release on their interim results for their ABI-5366 Herpes study. ✅ 94% reduction in HSV2 shedding rate ✅ 98% reduction in high viral load shedding rate, ✅ 94% reduction in genital lesion rate This is great news for all!! investor.assemblybio.com/news-release...

We were thrilled to attend @stihiv2025.org in Montreal! Herpes wasn’t always center stage — but our booth, panels, and conversations made sure it had a voice. Read about our experience, what we learned, and why the fight is far from over! #SilentNoMore herpescureadvocacy.com/2025/08/09/h...

We are so excited to be here at @stihiv2025.org! Stop by our booth T6 to learn more about our work to advance new therapies for HSV - and win a prize! #Herpes #CureHSV #SilentNoMore

Great news from Aicuris! We look forward to seeing their next steps! #Aicuris #Herpes #CureHSV #SilentNoMore www.aicuris.com/press-releas...

herpescureadvocacy.com/2025/07/26/c... #CRISPR